You are here

17-12-2019 | Portrait image © University of Helsinki - Illustration: Legend: The new artificially cloaked viral-based nanovaccines for cancer immunotherapeutic applications. © University of Helsinki 3 mins read

Why viruses coated with peptides could hold the key to cancer immunity

A targeted and personalised method for triggering the body’s immune response could transform how we treat cancer. Thanks to a grant from the European Research Council (ERC), an inspired idea has been developed in the lab and turned into a ground-breaking commercial opportunity.

08-08-2019 | © istockphoto.com - Ralf Geithe Picture:© Emma Master 2 mins read

Newly discovered proteins boost biomaterials market

New families of proteins and enzymes will enable the development of novel plant-based biomaterials, potentially providing viable sustainable and renewable alternatives to plastics and other fossil-fuel-derived materials and chemicals.